Carolyn Mies

Biochemistry, Genetics and Molecular Biology · Life Sciences

41h-index5.1kcitations123works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Breast Cancer Treatment Studies(30), Breast Lesions and Carcinomas(24), Cancer Risks and Factors(19), Estrogen and related hormone effects(12), MRI in cancer diagnosis(11)

Publications123 total

Metastatic breast cancer through the Oncotype DX Breast Recurrence Score®: insights from a small cohort study
Breast Cancer Research and Treatment·2025
Supplementary Table 4 from Circulating Sex Hormones and Terminal Duct Lobular Unit Involution of the Normal Breast
2023Open Access
Supplementary Table 4 from Circulating Sex Hormones and Terminal Duct Lobular Unit Involution of the Normal Breast
2023Open Access
Supplementary Table 3 from Circulating Sex Hormones and Terminal Duct Lobular Unit Involution of the Normal Breast
2023Open Access
Supplementary Table 1 from Circulating Sex Hormones and Terminal Duct Lobular Unit Involution of the Normal Breast
2023Open Access
Supplementary Table 1 from Circulating Sex Hormones and Terminal Duct Lobular Unit Involution of the Normal Breast
2023Open Access
Data from Circulating Sex Hormones and Terminal Duct Lobular Unit Involution of the Normal Breast
2023Open Access
Supplementary Table 2 from Circulating Sex Hormones and Terminal Duct Lobular Unit Involution of the Normal Breast
2023Open Access
Supplementary Table 3 from Circulating Sex Hormones and Terminal Duct Lobular Unit Involution of the Normal Breast
2023Open Access
Supplementary Table 6 from Circulating Sex Hormones and Terminal Duct Lobular Unit Involution of the Normal Breast
2023Open Access
Supplementary Table 5 from Circulating Sex Hormones and Terminal Duct Lobular Unit Involution of the Normal Breast
2023Open Access
Data from Circulating Sex Hormones and Terminal Duct Lobular Unit Involution of the Normal Breast
2023Open Access
Supplementary Table 5 from Circulating Sex Hormones and Terminal Duct Lobular Unit Involution of the Normal Breast
2023Open Access
Supplementary Table 2 from Circulating Sex Hormones and Terminal Duct Lobular Unit Involution of the Normal Breast
2023Open Access
Supplementary Table 6 from Circulating Sex Hormones and Terminal Duct Lobular Unit Involution of the Normal Breast
2023Open Access
Abstract PD15-05: Assessment of estrogen receptor (ESR1) mRNA expression for prediction of extended aromatase inhibitor benefit in HR-positive breast cancer using NRG Oncology/NSABP B-42
Cancer Research·2022
Abstract PS5-37: The feasibility of obtaining oncotype DX breast recurrence score® results from metastatic sites of patients with hormone receptor positive metastatic breast cancer
Cancer Research·2021
Pathologic Complete Response Predicts Recurrence-Free Survival More Effectively by Cancer Subset: Results From the I-SPY 1 TRIAL—CALGB 150007/150012, ACRIN 6657
UNC Libraries·2020Open Access
Chemotherapy response and recurrence-free survival in neoadjuvant breast cancer depends on biomarker profiles: results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657)
UNC Libraries·2020Open Access
Polygenic risk score for the prediction of breast cancer is related to lesser terminal duct lobular unit involution of the breast
npj Breast Cancer·2020· 22 citedOpen Access
page 1 of 7Next →

Frequent Co-authors

Bruce D. Minsky(9), Mark Rosen(9), Tyvin A. Rich(8), Abram Recht(7), Michael D. Feldman(7), Angela DeMichele(6), John T. Chaffey(6), Mitchell D. Schnall(4), Ahmed Ashraf(4), Despina Kontos(4), Laura J. Esserman(3), Lisa A. Carey(3), Christina Yau(3), Chad Livasy(3), David C. Chhieng(3), Baljit Singh(3), Joseph T. Rabban(3), Dilip D. Giri(3), Dania Daye(3), Anant Madabhushi(3)